טוען...
Novel Immunotherapies for Multiple Myeloma
PURPOSE OF REVIEW: The treatment landscape of multiple myeloma is rapidly changing; however, despite improvement in patients’ survival, it still remains a largely incurable disease. One hallmark of myeloma is substantial immune dysfunction leading to an increased infection rate and the inability of...
שמור ב:
| הוצא לאור ב: | Curr Hematol Malig Rep |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693669/ https://ncbi.nlm.nih.gov/pubmed/28819882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-017-0397-7 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|